A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo

Journal: Nature Biotechnology

Published: 2018-02-12

DOI: 10.1038/nbt.4071

Affiliations: 16

Authors: 19

Go to article
Institutions FC
CAS Key Laboratory of Nanosystem and Hierarchical Fabrication, NCNST CAS, China 0.16
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, IHEP CAS, China 0.16
CAS Center for Excellence in Nanoscience, NCNST CAS, China 0.16
Institute of Zoology (IOZ), CAS, China 0.11
University of Chinese Academy of Sciences (UCAS), China 0.07
QIMR Berghofer Medical Research Institute, Australia 0.05
Institute of Life and Health Engineering, JNU, China 0.05
ASU School of Molecular Sciences, United States of America (USA) 0.04
ASU Center for Molecular Design and Biomimetics, United States of America (USA) 0.04
ASU School of Life Sciences (SOLS), United States of America (USA) 0.04
ASU Center for Immunotherapy, Vaccines and Virotherapy (B-CIVV), United States of America (USA) 0.04
Department of Integration of Chinese and Western Medicine, PUHSC PKU, China 0.03
School of Basic Medical Sciences, PUHSC PKU, China 0.03
School of Pharmaceutical Sciences, JLU, China 0.01
Academy for Advanced Interdisciplinary Studies (AAIS), PKU, China 0.01
Center for Life Sciences (CLS), PKU, China 0.01

Return